Evaluation of Rehabilitation Results in the Single-sided Deafness With Cochlear Implantation

Launched by CHINESE PLA GENERAL HOSPITAL · Jun 22, 2022

Keywords

ClinConnect Summary

This clinical trial is examining how effective cochlear implants are for individuals with single-sided deafness (SSD) or asymmetrical hearing loss (AHL). SSD means that a person has significant hearing loss in one ear while the other ear has normal or mild hearing loss. The goal is to understand how cochlear implants can help improve hearing and communication skills in people affected by these conditions.

To participate in this trial, you need to be 12 years old or older, have lost hearing after learning to speak, and be able to take part in hearing tests in noisy environments. You should also have normal mental and physical development. However, if you have certain ear problems or cannot communicate in Mandarin, you won't be eligible for this study. If you join, you can expect to undergo tests to see how well the cochlear implant works for you and how it helps with your hearing and daily activities. This research aims to enhance understanding and treatment of hearing loss, especially in children and young adults.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age: 12 years old and above
• • 2. Language ability: postlingual deafness, able to cooperate with sentence test in noise
• • 3. Normal mental, intelligence and motor development
• • 4. Patients who meet the diagnosis of single-sided deafness and asymmetric hearing loss
• Exclusion Criteria:
• • 1. Cochlear malformation (except large vestibular aqueduct syndrome)
• • 2. Retrocochlear lesions
• • 3. Incomplete implantation of cochlear implant electrodes
• • 4. Non-Chinese Mandarin communication